Benchmark sells off its genetics arm

The aquaculture specialist is going through a major overhaul

Published on December 13, 2024

Sells division for £260mn
Savings benefits to trickle through

It was all change at Benchmark Holdings (BMK) as the aquaculture biotechnology company announced both a change in chairman, with Tripp Lane taking over from the retiring Peter George, and the post-period sale of the company’s genetics business to Novo Holdings for up to £260mm.

This is subscriber only content

Start your trial to keep reading

PRINT AND DIGITAL

Get 12 weeks for £12

Essential access to the website and app
Magazine delivered every week
Investment ideas, tools and analysis

Already a subscriber? Sign in